Scarica l'app Stockscreener
0.7073
3.71%
0.0253
Dopo l'orario di chiusura:
.71
0.0027
+0.38%
Precedente Chiudi:
$0.682
Aprire:
$0.69
Volume 24 ore:
57,323
Relative Volume:
0.32
Capitalizzazione di mercato:
$98.54M
Reddito:
$78.46M
Utile/perdita netta:
$2.75M
Rapporto P/E:
70.73
EPS:
0.01
Flusso di cassa netto:
$-12.42M
1 W Prestazione:
+1.19%
1M Prestazione:
+40.78%
6M Prestazione:
+78.39%
1 anno Prestazione:
+1.04%
Intervallo 1D:
$0.655
$0.7074
Intervallo di 1 settimana:
$0.6301
$0.7074
Portata 52W:
$0.331
$0.8325
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Nome
Xtant Medical Holdings Inc
Settore
Industria
Telefono
406-388-0480
Indirizzo
664 Cruiser Lane, Belgrade, MT
Confronta XTNT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.7073 | 97.39M | 78.46M | 2.75M | -12.42M | 0.01 |
|
ABT
Abbott Laboratories
|
133.94 | 231.14B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.83 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.10 | 146.12B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.00 | 105.64B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.77 | 45.60B | 5.54B | 4.18B | 623.10M | 7.00 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-05 | Iniziato | BTIG Research | Buy |
| 2018-11-15 | Reiterato | Maxim Group | Buy |
| 2018-02-14 | Reiterato | Maxim Group | Buy |
Xtant Medical Holdings Inc Borsa (XTNT) Ultime notizie
Xtant Medical Unveils OsteoFactor Pro for Bone Healing - Precedence Research
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Xtant Medical launches OsteoFactor Pro for bone repair By Investing.com - Investing.com South Africa
Xtant Medical Announces the Launch of OsteoFactor Pro™ - Ortho Spine News
Xtant Medical Holdings, Inc. Announces the Launch of OsteoFactor Pro - marketscreener.com
Xtant Medical launches OsteoFactor Pro for bone repair - Investing.com
Xtant Medical Introduces First-Ever Complete Orthobiologic Portfolio with New Bone Growth Technology - Stock Titan
Xtant Medical’s Earnings Call Highlights Growth and Optimism - TipRanks
Earnings call transcript: Xtant Medical Q1 2025 shows revenue growth and stock surge - Investing.com Nigeria
Xtant Medical outlines 8–11% revenue growth target for 2025 as company completes vertical integration and launches new products - MSN
Xtant Medical (XTNT) Files to Sell Over 73 Million Shares of Com - GuruFocus
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q1 2025 Earnings Call Transcript - Insider Monkey
Xtant Medical’s Q1 2025 revenue increases 18% to USD 32.9M - Medical Buyer
Xtant Medical Reports Strong Q1 2025 Results - TipRanks
Xtant Medical Q1 2025 Earnings Call Transcript - MarketBeat
Xtant Medical Reports First Quarter 2025 Financial Results - Yahoo Finance
Xtant Medical Holdings Inc (XTNT) Q1 2025: Everything You Need T - GuruFocus
Xtant Medical (XTNT) Projected to Post Quarterly Earnings on Monday - Defense World
Xtant Medical Sets Q1 2025 Earnings Date: MedTech Leader to Discuss Surgical Solutions Growth on May 12 - Stock Titan
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Shares Acquired by Renaissance Technologies LLC - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
How to interpret Xtant Medical Holdings Inc (XTNT)’s stock chart patterns - uspostnews.com
Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance - GuruFocus
Revolutionary Bone Graft Technology: Xtant Medical Unveils Trivium With 20-Year Proven Process - Stock Titan
Analysts Offer Insights on Healthcare Companies: Viatris (VTRS), Xtant Medical Holdings (XTNT) and Medtronic (MDT) - The Globe and Mail
Xtant Medical Holdings Inc (AMEX: XTNT) Has Great Upside Potential - stocksregister.com
Xtant Medical announces secondary private sale of existing shares - Medical Buyer
Xtant Medical Ends Investor Agreement After Share Sale - TipRanks
Xtant Medical secures investor support, projects Q1 revenue growth By Investing.com - Investing.com South Africa
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19% - Ortho Spine News
Xtant Medical Announces Secondary Private Sale Of Existing Shares By Orbimed - marketscreener.com
Major Shakeup: OrbiMed Sells Entire Xtant Medical Stake as Revenue Surges 19% - Stock Titan
Orbimed advisors sells Xtant Medical stock for $30.7 million - Investing.com
Xtant Medical shares change hands in major stock purchase - Investing.com
Xtant Medical shares change hands in major stock purchase By Investing.com - Investing.com India
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus - ACCESS Newswire
Xtant Medical (NYSEAMERICAN:XTNT) Shares Cross Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec – Ortho Spine News - OrthoSpineNews
Spinal Fusion Device Market Forecast Report and Company - GlobeNewswire
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Xtant Medical Faces Risk of Share Distribution by Major Stakeholder, Threatening Stock Stability - MSN
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2024 Earnings Call Transcript - Insider Monkey
Xtant Medical’s Earnings Call: Mixed Outlook with Growth Plans - TipRanks
Earnings call transcript: Xtant Medical Q4 2024 misses EPS, stock drops - Investing.com India
Earnings call transcript: Xtant Medical Q4 2024 misses EPS, stock drops By Investing.com - Investing.com South Africa
Xtant Medical stock target cut to $2 at BTIG, retains buy rating By Investing.com - Investing.com South Africa
Xtant Medical stock target cut to $2 at BTIG, retains buy rating - Investing.com
Xtant Medical Holdings Inc Azioni (XTNT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.64%
0.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):